SRH Klinikum Karlsbad-Langensteinbach GmbH
- Address
- Guttmannstrasse 1, Langensteinbach, 76307 Karlsbad, Germany
SRH Klinikum Karlsbad-Langensteinbach GmbH - Cardiovascular and Wound Care Research
SRH Klinikum Karlsbad-Langensteinbach GmbH is a clinical research center with demonstrated expertise in cardiovascular medicine and advanced wound healing therapies. The center participates in innovative trials investigating novel therapeutic approaches for acute cardiac events and chronic vascular conditions, contributing to the advancement of emergency cardiovascular care and regenerative medicine.
- Acute myocardial infarction management and self-administered emergency therapies
- Acute ischemic stroke treatment in anticoagulated patients
- Chronic venous ulcer healing and regenerative cell-based therapies
The center's research portfolio demonstrates particular strength in cardiovascular emergencies, including studies on novel antiplatelet agents for recurrent AMI prevention and innovative approaches to intravenous thrombolysis in stroke patients receiving direct oral anticoagulants. Additionally, the facility conducts advanced investigations into regenerative medicine for therapy-resistant chronic venous ulcers, exploring cutting-edge cell-based treatments to improve wound closure outcomes in challenging vascular conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SRH Klinikum Karlsbad-Langensteinbach GmbH
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Allogeneic Skin-Derived ABCB5-Positive Dermal Mesenchymal Stromal Cells in Therapy-Resistant Chronic Venous Ulcers | Rheacell GmbH & Co. KG | Phase II | Not Recruiting | Aug 2021 | Nov 2025 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells | 1 | Unknown | 2021-08-18 | 2021-08-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.